Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment
Authors:
- 19 November 2017
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 235 (3) , 627-640
Abstract
Major depressive disorder (MDD) is a growing problem worldwide. Though, the etiology remains unresolved, circadian rhythm disturbances are frequently observed in MDD and thus is speculated to play a key role herein. The present study focuses on circadian rhythm disturbances in the chronic mild stress (CMS) animal model of depression and examined whether the atypical antidepressant, agomelatine, which is mediating its action via melatonergic and serotonergic receptors, is capable of resynchronizing the perturbed rhythm. Melatonin is often used as a marker of the circadian phase, but the functional and behavioral output is dictated on a cellular level by the molecular clock, driven by the clock genes. We applied in situ hybridization histochemistry to measure the expression levels of the core clock genes, period (Per) 1 and 2 and bone and muscle ARNT-like protein 1 (Bmal1), in multiple brain regions believed to be implicated in depression. Agomelatine showed an antidepressant-like effect in the sucrose consumption test and an anxiolytic-like profile in the elevated zero maze. We found that CMS increased nighttime melatonin release in rats and that agomelatine attenuated this effect. Stress was shown to have a time and region-specific effect on clock gene expression in the brain. Treatment with agomelatine failed to normalize clock gene expression, and the observed modifying effect on gene expression did not associate with the antidepressant-like effect. This suggests that the antidepressant actions of agomelatine are mainly independent of circadian rhythm synchronization and, in this regard, not superior to traditional antidepressants tested in our model.Keywords
This publication has 62 references indexed in Scilit:
- Circadian patterns of gene expression in the human brain and disruption in major depressive disorderProceedings of the National Academy of Sciences, 2013
- Circadian activity of the hypothalamic–pituitary–adrenal axis is differentially affected in the rat chronic mild stress model of depressionStress, 2012
- Memory facilitating effects of agomelatine in the novel object recognition memory paradigm in the ratPharmacology Biochemistry and Behavior, 2011
- Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague–Dawley rats: Effects of anxiolytic and anxiogenic agentsPharmacology Biochemistry and Behavior, 2011
- Pineal melatonin synthesis is altered in Period1 deficient miceNeuroscience, 2010
- The circadian basis of mood disorders: Recent developments and treatment implicationsEuropean Neuropsychopharmacology, 2008
- Neurobiology of depression: an integrated view of key findingsInternational Journal Of Clinical Practice, 2007
- Coordination of circadian timing in mammalsNature, 2002
- Clock genes in mammalian peripheral tissuesCell and tissue research, 2002
- Chronic mild stress-induced anhedonia: A realistic animal model of depressionNeuroscience & Biobehavioral Reviews, 1992